A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation

N/ACompletedNCT01519648

National Hematological Society, Russia808 enrolled

Overview

Estimate the rate of occurrence of Invasive Fungal Infections (IFIs) in patients with acute leukemia for the first 6 months of chemotherapy (that usually correspond to four courses of chemotherapy), and hematopoietic stem cells transplantation.

This multi-center observational study of IFI in high risk hematological patients, the study will investigate the epidemiology of IFI, describe antifungal strategy, proportion of antifungal prophylaxis, empiric therapy, pre-emptive therapy and targeted therapy in at-risk patients.

Study Type

OBSERVATIONAL

Enrollment

808

Conditions

Invasive Fungal Infections

Eligibility

Sex: ALLMin age: 1 YearMax age: 95 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosed with de novo or relapsed AL (AML, ALL)started chemotherapy * All newly allogeneic or autologous transplant recipients during the study period

Locations (1)

National Hematological Society

Moscow, Russia

Outcomes

Primary Outcomes

The Rate of Invasive Fungal Infections

Estimate the rate of IFIs in patients with acute leukemia for the first 6 months of chemotherapy (that usually correspond to four courses of chemotherapy), and hematopoietic stem cells transplantation.

Time frame: 6 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.